FDA Guides Drugmakers On Rare Disease Research
The U.S. Food and Drug Administration on Friday issued detailed guidance on common issues that arise when developing so-called orphan drugs for rare diseases, advising manufacturers on important research issues and...To view the full article, register now.
Already a subscriber? Click here to view full article